While we are focused on developing the best possible cannabinoid products, we believe that improving the health and wellbeing of patients goes beyond this. That’s why we are committed to investing in research and development.
In addition to continuing to invest in research and development in-house, we understand that a strong partnership with clinicians and researchers is key to expanding the industry and helping people.
By prioritising research, we have the power to discover the full potential of cannabinoid medicines in treating diseases and improving lives. That’s why we partner with key universities to undertake cannabis research and support their clinical trial programs.
Chris Wright, Brisbane local who was diagnosed with Tourette’s syndrome at the age of 12 is one of the first patients recruited for the trial run by Brisbane’s Wesley Medical Research. Read about the trial here.
We currently have a research partnership with the Hunter Medical Research Institute, a partner of the University of Newcastle. For more information about how to become a partner please contact us.